BioCentury | Oct 7, 2013

3Q Stock Wrap-Up: Make it a double

For the second time this year, all market cap segments closed the quarter in the black. Large caps valued at $5 billion and above gained ground for the fifth consecutive quarter. They added 12%, and...
BC Week In Review | Nov 23, 2009
Clinical News

ALD-201: Phase I data

Data from a double-blind Phase I trial in 20 patients showed that transendocardial injection of ALD-201 led to a mean reduction in ischemia as measured by SPECT cardiac imaging of 4% vs. a 3.7% mean...
Items per page:
1 - 2 of 2